ID

27395

Description

PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib; ODM derived from: https://clinicaltrials.gov/show/NCT00548093

Link

https://clinicaltrials.gov/show/NCT00548093

Keywords

Versions (1)
  1. 11/13/17 11/13/17 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

November 13, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Carcinoma, Non Small Cell Lung NCT00548093

English

Eligibility Carcinoma, Non Small Cell Lung NCT00548093

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
advanced non-small cell lung cancer (nsclc)
Description

Non-Small Cell Lung Carcinoma Advanced

Data type

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C0205179
prior treatment with and failure of at least one regimen of chemotherapy and erlotinib.
Description

Chemotherapy Regimen Quantity failed | erlotinib

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0231175
UMLS CUI [2]
C1135135
prior treatment with no more than two chemotherapy regimens, including adjuvant or combined modality treatment.
Description

Chemotherapy Regimen Quantity | Chemotherapy, Adjuvant | Combined Modality Therapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [2]
C0085533
UMLS CUI [3]
C0009429
measurable disease .
Description

Measurable Disease

Data type

boolean

Alias
UMLS CUI [1]
C1513041
eastern cooperative oncology group (ecog) performance status 0-2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
tissue available for kras/ egfr testing
Description

Tissue Available kras gene (procedure) | Tissue Available egfr gene (procedure)

Data type

boolean

Alias
UMLS CUI [1,1]
C1292533
UMLS CUI [1,2]
C0470187
UMLS CUI [1,3]
C3537133
UMLS CUI [2,1]
C1292533
UMLS CUI [2,2]
C0470187
UMLS CUI [2,3]
C3497772
creatinine clearance > 40 cc/min or serum creat < 1.5 x uln
Description

Creatinine clearance measurement | Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C0373595
UMLS CUI [2]
C0201976
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
chemotherapy
Description

Chemotherapy

Data type

boolean

Alias
UMLS CUI [1]
C0392920
radiotherapy
Description

Therapeutic radiology procedure

Data type

boolean

Alias
UMLS CUI [1]
C1522449
biological or investigational agents within 4 weeks of baseline disease assessment.
Description

Biological Factors | Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0005515
UMLS CUI [2]
C0013230
patients who lack of tolerance of erlotinib therapy.
Description

Intolerance to erlotinib

Data type

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C1135135
Back to the top of the page

Similar models

Eligibility Carcinoma, Non Small Cell Lung NCT00548093

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Non-Small Cell Lung Carcinoma Advanced
Item
advanced non-small cell lung cancer (nsclc)
boolean
C0007131 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
Chemotherapy Regimen Quantity failed | erlotinib
Item
prior treatment with and failure of at least one regimen of chemotherapy and erlotinib.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C1135135 (UMLS CUI [2])
Chemotherapy Regimen Quantity | Chemotherapy, Adjuvant | Combined Modality Therapy
Item
prior treatment with no more than two chemotherapy regimens, including adjuvant or combined modality treatment.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0085533 (UMLS CUI [2])
C0009429 (UMLS CUI [3])
Measurable Disease
Item
measurable disease .
boolean
C1513041 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Tissue Available kras gene (procedure) | Tissue Available egfr gene (procedure)
Item
tissue available for kras/ egfr testing
boolean
C1292533 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C3537133 (UMLS CUI [1,3])
C1292533 (UMLS CUI [2,1])
C0470187 (UMLS CUI [2,2])
C3497772 (UMLS CUI [2,3])
Creatinine clearance measurement | Creatinine measurement, serum
Item
creatinine clearance > 40 cc/min or serum creat < 1.5 x uln
boolean
C0373595 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Chemotherapy
Item
chemotherapy
boolean
C0392920 (UMLS CUI [1])
Therapeutic radiology procedure
Item
radiotherapy
boolean
C1522449 (UMLS CUI [1])
Biological Factors | Investigational New Drugs
Item
biological or investigational agents within 4 weeks of baseline disease assessment.
boolean
C0005515 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Intolerance to erlotinib
Item
patients who lack of tolerance of erlotinib therapy.
boolean
C1744706 (UMLS CUI [1,1])
C1135135 (UMLS CUI [1,2])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial